These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21926961)

  • 1. Differential requirements for c-Myc in chronic hematopoietic hyperplasia and acute hematopoietic malignancies in Pten-null mice.
    Zhang J; Xiao Y; Guo Y; Breslin P; Zhang S; Wei W; Zhang Z; Zhang J
    Leukemia; 2011 Dec; 25(12):1857-68. PubMed ID: 21926961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inducible knockout of GRP78/BiP in the hematopoietic system suppresses Pten-null leukemogenesis and AKT oncogenic signaling.
    Wey S; Luo B; Tseng CC; Ni M; Zhou H; Fu Y; Bhojwani D; Carroll WL; Lee AS
    Blood; 2012 Jan; 119(3):817-25. PubMed ID: 21937694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of Pten in CD45-expressing cells leads to development of T-cell lymphoblastic lymphoma but not myeloid malignancies.
    Mirantes C; Dosil MA; Hills D; Yang J; Eritja N; Santacana M; Gatius S; Vilardell F; Medvinsky A; Matias-Guiu X; Dolcet X
    Blood; 2016 Apr; 127(15):1907-11. PubMed ID: 26773036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PTEN deletion and concomitant c-Myc activation do not lead to tumor formation in pancreatic beta cells.
    Radziszewska A; Choi D; Nguyen KT; Schroer SA; Tajmir P; Wang L; Suzuki A; Mak TW; Evan GI; Woo M
    J Biol Chem; 2009 Jan; 284(5):2917-2922. PubMed ID: 19056726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Myc is a target of RNA-binding motif protein 15 in the regulation of adult hematopoietic stem cell and megakaryocyte development.
    Niu C; Zhang J; Breslin P; Onciu M; Ma Z; Morris SW
    Blood; 2009 Sep; 114(10):2087-96. PubMed ID: 19542301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leukemogenic Ptpn11 causes fatal myeloproliferative disorder via cell-autonomous effects on multiple stages of hematopoiesis.
    Chan G; Kalaitzidis D; Usenko T; Kutok JL; Yang W; Mohi MG; Neel BG
    Blood; 2009 Apr; 113(18):4414-24. PubMed ID: 19179468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MYC levels govern hematopoietic tumor type and latency in transgenic mice.
    Smith DP; Bath ML; Metcalf D; Harris AW; Cory S
    Blood; 2006 Jul; 108(2):653-61. PubMed ID: 16537801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased c-Myc activity and DNA damage in hematopoietic progenitors precede myeloproliferative disease in Spa-1-deficiency.
    Tanaka H; Tamura A; Sekai M; Hamazaki Y; Minato N
    Cancer Sci; 2011 Apr; 102(4):784-91. PubMed ID: 21205094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pten loss in the bone marrow leads to G-CSF-mediated HSC mobilization.
    Tesio M; Oser GM; Baccelli I; Blanco-Bose W; Wu H; Göthert JR; Kogan SC; Trumpp A
    J Exp Med; 2013 Oct; 210(11):2337-49. PubMed ID: 24127490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTEN's regulation of VEGF and VEGFR1 expression and its clinical significance in myeloid leukemia.
    Zhiyong C; Wentong L; Xiaoyang Y; Ling P
    Med Oncol; 2012 Jun; 29(2):1084-92. PubMed ID: 21360018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Myc-mediated control of cell fate in megakaryocyte-erythrocyte progenitors.
    Guo Y; Niu C; Breslin P; Tang M; Zhang S; Wei W; Kini AR; Paner GP; Alkan S; Morris SW; Diaz M; Stiff PJ; Zhang J
    Blood; 2009 Sep; 114(10):2097-106. PubMed ID: 19372257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of acute lymphoblastic leukemia and myeloproliferative disorder in transgenic mice expressing p210bcr/abl: a novel transgenic model for human Ph1-positive leukemias.
    Honda H; Oda H; Suzuki T; Takahashi T; Witte ON; Ozawa K; Ishikawa T; Yazaki Y; Hirai H
    Blood; 1998 Mar; 91(6):2067-75. PubMed ID: 9490692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEAR1 attenuates megakaryopoiesis via control of the PI3K/PTEN pathway.
    Kauskot A; Vandenbriele C; Louwette S; Gijsbers R; Tousseyn T; Freson K; Verhamme P; Hoylaerts MF
    Blood; 2013 Jun; 121(26):5208-17. PubMed ID: 23667054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coordinate suppression of B cell lymphoma by PTEN and SHIP phosphatases.
    Miletic AV; Anzelon-Mills AN; Mills DM; Omori SA; Pedersen IM; Shin DM; Ravetch JV; Bolland S; Morse HC; Rickert RC
    J Exp Med; 2010 Oct; 207(11):2407-20. PubMed ID: 20956547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-106b promotes pituitary tumor cell proliferation and invasion through PI3K/AKT signaling pathway by targeting PTEN.
    Zhou K; Zhang T; Fan Y; Serick ; Du G; Wu P; Geng D
    Tumour Biol; 2016 Oct; 37(10):13469-13477. PubMed ID: 27465551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pten mediates Myc oncogene dependence in a conditional zebrafish model of T cell acute lymphoblastic leukemia.
    Gutierrez A; Grebliunaite R; Feng H; Kozakewich E; Zhu S; Guo F; Payne E; Mansour M; Dahlberg SE; Neuberg DS; den Hertog J; Prochownik EV; Testa JR; Harris M; Kanki JP; Look AT
    J Exp Med; 2011 Aug; 208(8):1595-603. PubMed ID: 21727187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of the loss of Pten protein determines disease severity in a mouse model of myeloid malignancy.
    Liu YL; Yan Y; Webster C; Shao L; Lensing SY; Ni H; Feng W; Colorado N; Pathak R; Xiang Z; Hauer-Jensen M; Li S; Zhou D; Emanuel PD
    Blood; 2016 Apr; 127(15):1912-22. PubMed ID: 26764354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTEN deficiency is fully penetrant for prostate adenocarcinoma in C57BL/6 mice via mTOR-dependent growth.
    Blando J; Portis M; Benavides F; Alexander A; Mills G; Dave B; Conti CJ; Kim J; Walker CL
    Am J Pathol; 2009 May; 174(5):1869-79. PubMed ID: 19395652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus-triggered PTEN/β-catenin/c-Myc signaling enhances PD-L1 expression to promote immune evasion.
    Sun Y; Yu M; Qu M; Ma Y; Zheng D; Yue Y; Guo S; Tang L; Li G; Zheng W; Wang M; Guo D; Li C
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G162-G173. PubMed ID: 31604033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitor of c-Myc 10058-F4 inhibits proliferation and induces apoptosis in acute leukemia cells, irrespective of PTEN status.
    Bashash D; Sayyadi M; Safaroghli-Azar A; Sheikh-Zeineddini N; Riyahi N; Momeny M
    Int J Biochem Cell Biol; 2019 Mar; 108():7-16. PubMed ID: 30639430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.